Early Access — free while we kick the tires
EdgarHawk

Pichl Daniel

Chief People Officer

Officer
1 filing analyzed · 1 company · Latest 2025-02-12

Companies

Company Buys Sells Direction
SpringWorks Therapeutics, Inc. SWTX 0 5 Net selling

Activity

February 2025
Sell
29,750 shares
$1,617,329
Significance 6/10

CPO Daniel Pichl sells 29,750 shares at $54.36 avg; 100% of his prior SWTX sales were well-timed (stock fell post-trade).

Daniel Pichl, Chief People Officer, executed 3 separate sales totaling 29,750 shares for $1,617,329.10 on 2025-02-10, reducing his holdings by 37.0% to 50,762 shares post-transaction. The sales occurred at an average price of $54.36, below the current price of $59.28. Remarkably, all 5 of Pichl's prior open-market sales at SWTX were well-timed, with negative 90-day returns following each sale—a 100% timing pattern at this ticker. His cross-ticker track record shows a 90-day well-timed rate of 100.00%, indicating consistent ability to sell before subsequent declines. Against this backdrop, the stock is at its 52-week high ($59.28) and has surged +60.2% over the last 30 days and +62.2% over 90 days—a sharp ascent that raises the question whether the insider's historical sell-timing edge may translate to this current transaction, especially given that the company remains unprofitable with a net income of $-53,530,000.00 in the latest quarter.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access